The U.S. FDA has approved a supplemental new drug application for dutasteride for the treatment of symptomatic

Laurie Barclay, MD Oct. 8, 2002 — Most men with prostate cancer want ready access to prostate-specific

NEW YORK (Reuters Health) Oct 08 – More than 65% of African-American patients with overt type 2

By Steven Reinberg NEW YORK (Reuters Health) Oct 08 – For patients with prostate cancer who are

Laurie Barclay, MD Oct. 9, 2002 —  Editor’s Note: The Office of the Inspector General (OIG) is

Laurie Barclay, MD Oct. 4, 2002 —  Ureteroscopy with holmium laser lithotripsy is a safe and effective

NEW YORK (Reuters Health) Oct 04 – More than a third of peritoneal dialysis (PD) patients are

NEW YORK (Reuters Health) Oct 04 – Findings from a new study indicate that there is a

In patients with prostate cancer that has spread to bone, treatment with zoledronic acid reduces the risk

Comparison between programs of aggressive, and less aggressive, prostate cancer screening and treatment in two American states